Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupinder Brar

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Lancet. Psychiatry|May 31, 2020
Innovative strategies to support physical distancing among individuals with active addictionPaxton Bach, Samantha Robinson, Christy Sutherland, et al.
American Journal of Clinical Pathology|September 14, 2021
Histologic Findings and Tissue B-Cell Depletion in Endoscopic Mucosal Biopsy Specimens of the Gastrointestinal Tract After Treatment With RituximabMichel Kmeid, Mahmoud Aldyab, Rupinder Brar, et al.
Drug and Alcohol Review|October 14, 2021
Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case seriesDaniel Shearer, Samantha Young, Nadia Fairbairn, et al.
Drug and Alcohol Review|May 14, 2026
Safe Supply at Insite, North America's First Supervised Consumption Site: A Case Report of Reduced Harms From the Toxic Drug Supply in a Client Prescribed Powdered Fentanyl AlternativeNadia Fairbairn, Elaine Hu, Mark Lysyshyn, et al.
BMJ Case Reports|March 28, 2020
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approachMackenzie Duncan Gregory Caulfield, Rupinder Brar, Christy Sutherland, et al.
Journal of Addiction Medicine|August 10, 2020
Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case SeriesRupinder Brar, Nadia Fairbairn, Kate Colizza, et al.
Health & Social Care in the Community|July 19, 2022
Primary care embedded within permanent supportive housing for people who use substances: A qualitative study examining healthcare access in Vancouver, CanadaLaura MacKinnon, Nick Kerman, M Eugenia Socías, et al.
The American Journal of Surgical Pathology|October 3, 2022
PSMA Immunohistochemistry in Hepatic Neoplasms: A Promising Diagnostic Marker With Potential Theranostic ApplicationsMichel Kmeid, Young Nyun Park, Taek Chung, et al.
Contemporary Clinical Trials|March 21, 2020
Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trialM Eugenia Socias, Evan Wood, Huiru Dong, et al.
The International Journal on Drug Policy|April 14, 2023
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergenciesKaren Giang, Reith Charlesworth, Madison Thulien, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Lancet. Psychiatry|May 31, 2020
Innovative strategies to support physical distancing among individuals with active addictionPaxton Bach, Samantha Robinson, Christy Sutherland, et al.
American Journal of Clinical Pathology|September 14, 2021
Histologic Findings and Tissue B-Cell Depletion in Endoscopic Mucosal Biopsy Specimens of the Gastrointestinal Tract After Treatment With RituximabMichel Kmeid, Mahmoud Aldyab, Rupinder Brar, et al.
Drug and Alcohol Review|October 14, 2021
Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case seriesDaniel Shearer, Samantha Young, Nadia Fairbairn, et al.
Drug and Alcohol Review|May 14, 2026
Safe Supply at Insite, North America's First Supervised Consumption Site: A Case Report of Reduced Harms From the Toxic Drug Supply in a Client Prescribed Powdered Fentanyl AlternativeNadia Fairbairn, Elaine Hu, Mark Lysyshyn, et al.
BMJ Case Reports|March 28, 2020
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approachMackenzie Duncan Gregory Caulfield, Rupinder Brar, Christy Sutherland, et al.
Journal of Addiction Medicine|August 10, 2020
Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case SeriesRupinder Brar, Nadia Fairbairn, Kate Colizza, et al.
Health & Social Care in the Community|July 19, 2022
Primary care embedded within permanent supportive housing for people who use substances: A qualitative study examining healthcare access in Vancouver, CanadaLaura MacKinnon, Nick Kerman, M Eugenia Socías, et al.
The American Journal of Surgical Pathology|October 3, 2022
PSMA Immunohistochemistry in Hepatic Neoplasms: A Promising Diagnostic Marker With Potential Theranostic ApplicationsMichel Kmeid, Young Nyun Park, Taek Chung, et al.
Contemporary Clinical Trials|March 21, 2020
Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trialM Eugenia Socias, Evan Wood, Huiru Dong, et al.
The International Journal on Drug Policy|April 14, 2023
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergenciesKaren Giang, Reith Charlesworth, Madison Thulien, et al.
Pageof 4